PRODRUGS

被引：30

作者：

WALLER, DG

GEORGE, CF

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 28卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb03535.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：497 / 507

页数：11

共 58 条

[1] CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J].

ALBERT, A .

NATURE, 1958, 182 (4633) :421-423

[2]

ANDERSON JA, 1980, ARCH OPHTHALMOL-CHIC, V98, P350

[3] NEW POTENT INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME [J].

ATTWOOD, MR ;

FRANCIS, RJ ;

HASSALL, CH ;

KROHN, A ;

LAWTON, G ;

NATOFF, IL ;

NIXON, JS ;

REDSHAW, S ;

THOMAS, WA .

FEBS LETTERS, 1984, 165 (02) :201-206

[4]

BODOR N, 1987, CONTROLLED DRUG DELI, P337

[5]

BROCK PG, 1982, EUR J RHEUMATOL INFL, V5, P318

[6] PROLONGED EFFECT OF SULFINPYRAZONE ON COLLAGEN-INDUCED PLATELET-AGGREGATION INVIVO [J].

BUCHANAN, MR ;

ROSENFELD, J ;

HIRSH, J .

THROMBOSIS RESEARCH, 1978, 13 (05) :883-892

[7] CORONARY THROMBOLYSIS [J].

CAIRNS, JA ;

COLLINS, R ;

FUSTER, V ;

PASSAMANI, ER .

CHEST, 1989, 95 (02) :S73-S87

[8]

CLINCH D, 1986, PEPTIC ULCER ITS DRU

[9]

COLVIN M, 1976, CANCER RES, V36, P1121

[10] FLUPHENAZINE ENANTHATE AND FLUPHENAZINE DECANOATE - INTRAMUSCULAR INJECTION AND ESTERIFICATION AS REQUIREMENTS FOR SLOW-RELEASE CHARACTERISTICS IN DOGS [J].

DREYFUSS, J ;

SHAW, JM ;

ROSS, JJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (09) :1310-1315

← 1 2 3 4 5 6 →